atilla soran, md, mph, facs professor of surgery - lookusfile.lookus.net/amhd/dr.atilla...

53
Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıcı Cerrahiler: Profilaktik Cerrahi

Upload: hakhue

Post on 05-Mar-2018

226 views

Category:

Documents


7 download

TRANSCRIPT

Page 1: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

Atilla Soran, MD, MPH, FACSProfessor of Surgery

Meme Kanserinde Risk Azaltıcı Cerrahiler: Profilaktik Cerrahi

Page 2: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

Modifiye edilebilir Risk factorleri

• Behavioral factors

BMIAlcohol useSmokingExercise

• Dietary factors

Total fat intakeSaturated fat intake

• Ionizing radiation

• Hormone replacement

• Age

• Reproductive History

• Familial/genetic factors 

• Breast density

• Atypical/LCIS

• History of BC

• Ethnicity/Race

Modifiye edilemez faktorler

Page 3: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 4: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 5: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

BPMBSO

Bilateral profilaksi

Koruyucu ilac tedavisi

Yakin takip

Page 6: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

What do we know;

• Risk Reduction mastectomy – Reduces CBC incidence– Treats occult synchronous cancer– Prevents metachronous cancerBUT– irreversible/substantial– Complications– Unnecessary; absolute risk of CBC is low

» Survival benefit?• Alternatives

– Screening– Oophorectomy– Chemoprevention 

Page 7: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

Risk Azaltıcı Cerrahiler

Bilateral Profilaktik Mastektomi

Page 8: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 9: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

%6.8>20 yıl

Page 10: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 11: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 12: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 13: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 14: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

%3 absult kazanç, %2.8 okult Ca

Page 15: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 16: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 17: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 18: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

Risk azaltıcı Cerrahiler:Prophylactic oophorectomy

Page 19: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

Prophylactic oophorectomy in BRCA1mutation carriers: effect on breast cancer incidence

Rebbeck TR, et al. JNCI 1999; 91:1475-1479

Page 20: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

Estimates of the Time to Breast Cancer or BRCA‐Related Gynecologic Cancer after Salpingo‐Oophorectomy or Surveillance 

for Ovarian Cancer

Kauff ND, et al. N Engl J Med 2002; 346:1609-1615

(p = 0.006 by log-rank test)

Page 21: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 22: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

CPM

Page 23: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

RANDOMIZED TRIALS SHOW 

SURVIVAL  MASTECTOMY  =    SURVIVAL BCT

Newman et al. J Clin Onc. March 2005

Page 24: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

SURVIVALBreast Cancer Surgery Journey

1894

Halsted-RM

1967 Fisher MRM

1981- Fischer BCS

2000- BM

Page 25: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 26: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 27: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 28: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

MWH data05 06 07 08 09

BCS 606 629  683  706  618

All Mastectomy 272(31%) 

321(35%) 

377(35%) 

435 (38%) 

409(40%)

Mast+CPM+Reconstruc.

55(20%) 22(40%)

67(21%) 30(45%)

115(31%) 48(42%)

111(26%) 77(69%)

105 (26%)72(69%)

Total 878 905 1060 1141 1027

(2009) All Uni. Mastectomy + reconst: 25%

Page 29: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

MWH

01020304050607080

Year 2005-2009

%of

pts TM

TM+CPMTM+CPM+RECONST

TM 31 35 35 38 40

TM+CPM 20 21 31 26 26

TM+CPM+RECONST

40 45 42 69 69

1 2 3 4 5

Page 30: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

Tahmin edilebilir yıllık riskler (%)

•Yaş<30 .4‐1.3•Yaş>50 .2‐.4•HR negatif .2‐.6•HR (+) .1‐.4•2.‐3. derece akraba  minimal•1.derece akraba .2‐.8•Çoklu akraba 1.‐2. .4‐1.3•BRCA mutasyon .9‐3

•Ingrid et al.JACS. 2013

Page 31: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

CBC 

DFS

Page 32: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 33: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

Do patients with unilateral breast cancer benefit from more aggressive surgery ?

Page 34: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

%4.3 BC survi de artma

Page 35: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 36: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 37: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 38: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 39: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 40: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 41: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

CPM‐MRIMRI  at diagnosis increased from 1.3%  to  36.3% (1997‐2005) 

Page 42: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 43: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

Date of download: 5/23/2014 Copyright © 2014 American Medical Association. All rights reserved.

From: Social and Clinical Determinants of Contralateral Prophylactic Mastectomy

JAMA Surg. 2014;():. doi:10.1001/jamasurg.2013.5689

Study Flow DiagramSEER indicates Surveillance, Epidemiology, and End Results.

Page 44: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

Date of download: 5/23/2014 Copyright © 2014 American Medical Association. All rights reserved.

From: Social and Clinical Determinants of Contralateral Prophylactic MastectomyJAMA Surg. 2014;():. doi:10.1001/jamasurg.2013.5689

Predicted Probabilities of Receipt of Treatments by Clinical Indications and Worry About RecurrenceAdjusted for age, race/ethnicity, education, income, stage, and study site.

Page 45: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 46: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 47: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 48: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 49: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

Potential contributing factors

• Fear a 2nd BC• Changing perception

BCS /RT• Fear of CT/RT/HT• Martial status• Difficult/long surveillance • Experience of Chemoprevention • Socioeconomic status• Body image

• Media reports• Public awareness

•Age•Family history of BC•BRCA1/2 genetic testing•Invasive lobular histology•DCIS•Hormone replacement therapy

•Preoperative MRI w/ additional biopsy•Diagnostic difficulties for CBC•Failed attempt at BCT•Improved mastectomy •Reconstruction

Page 50: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

Kathy Bates: The actress, who beat ovarian cancer close to a decade ago, shared last month that she had been diagnosed with breast cancer and underwent a double mastectomy.

Allyn Rose, Miss America Contestant, To Undergo Double Mastectomy To Prevent Breast Cancer

Double Mastectomy: Sharon Osbourne Undergoes Breast-Removal Surgery

CHRISTINA APPLEGATE: WHY SHE HAD A DOUBLE MASTECTOMY

Michelle Heaton speaks about her double mastectomy and says: “It’s the hardest thing in the world not being able to hold your child

"My chances of developing breast cancer have dropped from 87 percent to under 5 percent," Jolie wrote in a surprise op-ed published in …that applauded partner Brad Pitt's support. "I can tell my children that they don’t need to fear they will lose me to breast cancer."

Page 51: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc

Conclusion• Overall survival

– Selected pts most likely to benefit

• Risk reduction – Disease free survival

• Satisfaction w/cosmetic outcome• RR w Chemoprevention works in some pts and has side effects,

• Long term follow up is not always acceptable• It must be pt’s decision: CPM vs. alternative risk reduction procedures

Page 52: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc
Page 53: Atilla Soran, MD, MPH, FACS Professor of Surgery - LookUsfile.lookus.net/amhd/Dr.Atilla Soran.pdf · Atilla Soran, MD, MPH, FACS Professor of Surgery Meme Kanserinde Risk Azaltıc